Author:
Sundström Karin,Tran Trung Nam,Lundholm Cecilia,Young Cecilia,Sparén Pär,Dahlström Lisen Arnheim
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference43 articles.
1. GLOBOCAN 2002 cancer incidence. Mortality and prevalence worldwide. IARC CancerBase No. 5 version 2.0;Ferlay,2004
2. IARC. IARC Monographs on the evaluation of carcinogenic risks to humans, volume 90, human papillomaviruses. Lyon, France: International Agency on Cancer Research; 2007.
3. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women;Paavonen;Lancet,2009
4. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials;Ault;Lancet,2007
5. An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results;Schiller;Vaccine,2008
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献